Satraplatin or active metabolite kills prostate cancer in vitro

December 9, 2004

Treatment of prostate cancer cells with satraplatin or its active metabolite resulted in the killing of tumor cells, according to a poster presented at the American Association for Cancer Research's Basic, Translational, and Clinical Advances in Prostate Cancer meeting.